US$ 20.37
glp-1 receptor agonists in pediatric and adolescent obesity Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children GLP-1 Agonists For Obesity In
Description
19 , e13119 (2024)

The starting dosage is 0.8 milligrams (mg), increased to 2.5 mg after at least 30 days, and then to 5.5 mg after another 30 days

Given the increased potential for nausea and vomiting, it is important that the pre-sedation instructions allow for a period of withholding these drugs prior to sedation based on their half-life

Nevertheless, there is scope for further investigation in the youngest children with obesity to optimise weight loss treatment regimens and minimise side effects, important factors to ensure adherence to medication

JAMA psychiatry , 82 (1), 9498

Sleep and stress management Poor sleep and chronic stress both promote weight regain through hormonal mechanisms
